S&P 500 · Health Care · USD · FY end 2025-12-31
Regeneron Pharmaceuticals (REGN) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 14.34B | 4.50B | 41.48 | 4.08B |
| FY2024 | 14.20B | 4.41B | 38.34 | 3.66B |
| FY2023 | 13.12B | 3.95B | 34.77 | 3.88B |
| FY2022 | 12.17B | 4.34B | 38.22 | 4.42B |
| FY2021 | 16.07B | 8.08B | 71.97 | 6.53B |